18F-fluciclovine PET/CT and 18F-DCFPyL PET/CT in patients with biochemical recurrence of disease after radical prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial 18F-fluciclovine PET/CT en 18F-DCFPyL PET/CT
Latest Information Update: 11 Oct 2021
At a glance
- Drugs Piflufolastat F18 (Primary) ; Fluciclovine 18F
- Indications Adenocarcinoma; Prostate cancer
- Focus Diagnostic use
- Acronyms RENARD trial
- 11 Oct 2021 New trial record